Physician profile
Habib Samady
NPI 1043287832
$42,224.78
in general payments reported to CMS, 2019-2025
16 companies · $74.52 in 2025
The $74.52 reported for 2025 was less than what a typical Interventional Cardiology provider received nationally (typical 2025 total: $1,092).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $7,946 · 2020: $211 · 2021: $3,400 · 2022: $1,709 · 2023: $16K · 2024: $13K · 2025: $74.52.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Consulting Fee: $25K · Food and Beverage: $2,346 · Travel and Lodging: $1,788.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Consulting Fee | $24,825.00 |
| Food and Beverage | $2,345.77 |
| Travel and Lodging | $1,787.85 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Philips North America LLC | $37,096.11 | 2019-2025 | (9520) Igt Devices Undivided, (Bh4) Igt Devices Undivided, Coronary Other |
| Abbott Laboratories | $2,987.90 | 2019-2024 | Optis, Xience Skypoint, Coroflow |
| Edwards Lifesciences Corporation | $628.69 | 2022-2024 | Sapien 3 Ultra Resilia, Edwards Sapien 3 Ultra Transcatheter Heart Valve |
| Boston Scientific Corporation | $276.01 | 2021-2024 | Rotapro |
| Zoll Services LLC (A/K/A Zoll Lifecor Corp) | $242.37 | 2021-2024 | Lifevest |
| Medtronic Vascular, INC. | $211.35 | 2020 | |
| Shockwave Medical, INC | $191.41 | 2024 | Shockwave Ivl System With The Shockwave C2 Coronary Ivl Catheter, Shockwave Intravascular Lithotripsy (Ivl) System With The Shockwave C2+ Coronary |
| Medtronic, INC. | $180.51 | 2021-2023 | Onyx Frontier |
| Inari Medical, INC. | $118.97 | 2022-2023 | Ct Thrombectomy System Kit, Flowtriever Catheter, S |
| Artivion, INC. | $101.65 | 2022 | |
| Terumo Medical Corporation | $96.73 | 2021 | |
| Getinge USA Sales, LLC | $24.45 | 2022 | |
| Astrazeneca Pharmaceuticals LP | $23.59 | 2023 | Andexxa |
| Kestra Medical Technology Services, INC. | $23.02 | 2024 | Assure Wcd |
| Amgen INC. | $22.02 | 2021 |
1 company reported research payments only; those appear in the research section below.
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Habib Samady listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.